Third-quarter results for Medtronic (NYSE:MDT) included a timeline for a planned label expansion for its automated insulin ...

After an FDA warning, Medtronic has recalled two of its MiniMed insulin pump products that could be wirelessly interfered with by hackers. Medtronic thinks there’s no evidence that anyone using ...

WASHINGTON, D.C. — The U.S. Food and Drug Administration has issued a Class I recall, the most serious type, on Medtronic’s ...

Medtronic (NYSE:MDT) issued an urgent field safety notice in Europe related to multiple versions of its MiniMed insulin pump ...

In an “urgent medical device correction,” the company urges clinicians to remind patients to monitor their glucose levels during takeoffs and landings.

The U.S. Food and Drug Administration has approved Medtronic's MiniMed Paradigm insulin pump, which is also a glucose monitor. The U.S. Food and Drug Administration has approved Medtronic's ...

Medtronic posted a strong profit for Q3 of fiscal year 2025, though shares were down as its cardiac ablation product success ...

Shares of Medtronic (NYSE: MDT) are off to a fantastic start ... And in the highly competitive diabetes care segment, the new MiniMed 780G insulin pump system employs AI algorithms to predict and ...

Medtronic's stock lags peers due to growth challenges in the diabetes and hypertension markets. See why we recommend a sell ...

Shares of Medtronic (NYSE: MDT ... And in the highly competitive diabetes care segment, the new MiniMed 780G insulin pump system employs AI algorithms to predict and automatically adjust insulin ...